/PRNewswire/ ViewRay, Inc. (Nasdaq: VRAY) announced the election of Karen N. Prange to its Board of Directors by ViewRay s stockholders at its 2021 Annual.
ViewRay Inc. [NASDAQ: VRAY] slipped around -0.51 points on Tuesday, while shares priced at $6.12 at the close of the session, down -7.69%. The company report on May 25, 2021 that American Hospital in Istanbul, Turkey Purchases MRIdian® MRI-Guided Radiation Therapy System. Get the hottest stocks to
ViewRay Reports First Quarter 2021 Results
News provided by
Share this article
CLEVELAND, May 6, 2021 /PRNewswire/
ViewRay, Inc. (Nasdaq: VRAY) (the Company ) today announced financial results for the first quarter ended March 31, 2021.
First Quarter 2021 Highlights
Received seven new orders for MRIdian systems totaling $40.9 million, compared to four new orders totaling $22.6 million in the first quarter of 2020.
Total backlog increased to $264.3 million as of March 31, 2021, compared to $230.8 million as of March 31, 2020.
Total revenue of $15.5 million primarily from two revenue units, compared to $14.3 million primarily from three revenue units, including one system upgrade, in the first quarter of 2020.
Cash burn in the first quarter of 2021 was approximately $28 million, excluding the net proceeds from the January 2021 public offering, compared to approximately $36 million in the first quarter of 2020.
ViewRay Announces Conference Call for First Quarter 2021 Financial Results to be Held After Market on May 6, 2021 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
ViewRay Announces Departure of Chief Operating Officer
News provided by
Share this article
Share this article
CLEVELAND, March 15, 2021 /PRNewswire/ ViewRay, Inc. (Nasdaq: VRAY) ( the Company ) today announced that Shahriar Matin, Chief Operating Officer, will leave the Company effective March 31, 2021. Matin was named Chief Executive Officer designate of Cordis in its recently announced divestiture from Cardinal Health to private equity firm Hellman & Friedman. It has been a privilege to work alongside the ViewRay team, and I believe that MRIdian is unequivocally the future of radiation oncology, said Shahriar Matin, Chief Operating Officer. Departing ViewRay is difficult, but I am confident that the team we have built will execute on the opportunity to become standard of care.